Great Piece on Critical Decisions
Here is a well-written piece by The Global Mail discussing Critical Decisions. Take a look.
Chemotherapy drugs have become ridiculously expensive. Many new drugs come to market costing more than $100,000 per patient for a full course of treatment. Often, patients have to pay a significant portion of these costs. For example, a 20% co-insurance rate, typical for basic Medicare coverage, leaves patients responsible for more than $20,000 of chemotherapy costs,…
This summer I had the pleasure of speaking with a very intelligent journalist, who was working on an article about overtreatment in medical care. That article has just come out, and I thought I would give you a sample of it here: A few months ago, I went to my gynecologist looking for help with a…
Sepsis is a brutal killer. It often starts after a microorganism gets loose in your bloodstream, spreading to organs far and wide, releasing deadly toxins along the way. In response, your body releases toxins of its own, chemicals designed to kill the invading organism but that, all too often, damage your body, too, leaving you…
It is not an easy time to be a physician in the United States. Attempt to order an expensive test for a patient and an insurance company is likely to second guess your decision. Try upholding the bottom line for your medical practice and the government will probably start questioning whether you are overcharging for…
Here is my latest Critical Decisions video. This one gives a broad introduction to the reasons I wrote the book.
When is the treatment worse than the disease? When the high costs associated with care become a financial burden for patients and in many cases prevent them from protecting their health, contends Peter Ubel, MD, a 2007 recipient of a Robert Wood Johnson Foundation (RWJF) Investigator Award in Health Policy Research. “We have reached a…